EV/EBITDA spoločnosti NeuroVive Pharmaceutical AB
Aká je hodnota metriky EV/EBITDA spoločnosti NeuroVive Pharmaceutical AB?
Hodnota metriky EV/EBITDA spoločnosti NeuroVive Pharmaceutical AB je N/A
Aká je definícia metriky EV/EBITDA?
EV/EBITDA je podniková hodnota vydelená EBITDA (zisk pred odpočítaním úrokov, daní, odpisov, a amortizácie). Meria nákladnosť akcie a používa sa na porovnávanie spoločností medzi sebou častejšie ako P/E ratio. Meria cenu akú investor zaplatí za pohyb hotovosti v spoločnosti.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA spoločností v sektore Health Care sektor na OTC v porovnaní so spoločnosťou NeuroVive Pharmaceutical AB
Čomu sa venuje spoločnosť NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Firmy s metrikou ev/ebitda podobnou spoločnosti NeuroVive Pharmaceutical AB
- Hodnota metriky EV/EBITDA spoločnosti Long Blockchain je N/A
- Hodnota metriky EV/EBITDA spoločnosti Long Blockchain je N/A
- Hodnota metriky EV/EBITDA spoločnosti Allot Ltd je N/A
- Hodnota metriky EV/EBITDA spoločnosti Seneca Biopharma Inc je N/A
- Hodnota metriky EV/EBITDA spoločnosti Cantex Mine Development je N/A
- Hodnota metriky EV/EBITDA spoločnosti Rockwealth Resources je N/A
- Hodnota metriky EV/EBITDA spoločnosti NeuroVive Pharmaceutical AB je N/A
- Hodnota metriky EV/EBITDA spoločnosti SandRidge Permian Trust je N/A
- Hodnota metriky EV/EBITDA spoločnosti NetMed je N/A
- Hodnota metriky EV/EBITDA spoločnosti Tongda Hong Tai je N/A
- Hodnota metriky EV/EBITDA spoločnosti Aspire Mining je N/A
- Hodnota metriky EV/EBITDA spoločnosti Linius Technologies je N/A
- Hodnota metriky EV/EBITDA spoločnosti Cloud DX je N/A